Oncoinvent ASA Logo

Oncoinvent ASA

OCIN | Euronext Growth

Overview

Corporate Details

ISIN(s):
NO0010779341 (+1 more)
LEI:
54930076H5GUZRMSNR39
Country:
Norway
Address:
Gullhaugveien 7, 0484 Oslo
Sector:
Health Care
Industry:
Biotechnology

Description

Oncoinvent ASA is a Norwegian biotechnology company developing targeted radiopharmaceuticals to provide innovative treatments for cancer patients worldwide.

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-07-03 15:45
Regulatory News Service
Oncoinvent ASA: Notice of Extraordinary General Meeting - Attachment: Oncoinven…
Norwegian 190.2 KB
2025-07-03 15:45
Regulatory News Service
Oncoinvent ASA: Notice of Extraordinary General Meeting
Norwegian 3.6 KB
2025-06-30 22:11
Investment Company Reports
Announcement of fully underwritten rights issue - Attachment: Attachment_overvi…
English 101.2 KB
2025-06-30 22:11
Regulatory News Service
Announcement of fully underwritten rights issue - Attachment: Joint_Press_Relea…
English 143.1 KB
2025-06-30 22:11
Regulatory News Service
Announcement of fully underwritten rights issue
English 20.6 KB
2025-06-30 22:01
Regulatory News Service
BerGenBio and Oncoinvent, a rising innovator in radiopharmaceutical cancer ther…
English 136.0 KB
2025-06-30 22:01
Regulatory News Service
BerGenBio and Oncoinvent, a rising innovator in radiopharmaceutical cancer ther…
English 19.0 KB
2025-06-18 08:01
Inside Information Statement
Oncoinvent (ONCIN): Invitation to Presentation of Positive Final Data from Phas…
English 134.6 KB
2025-06-18 08:01
Regulatory News Service
Oncoinvent (ONCIN): Invitation to Presentation of Positive Final Data from Phas…
English 3.7 KB
2025-06-18 07:00
Earnings Release
Oncoinvent Announces Positive Final Data from Phase 1/2a Trial of Radspherin® i…
English 230.2 KB
2025-06-18 07:00
Earnings Release
Oncoinvent Announces Positive Final Data from Phase 1/2a Trial of Radspherin® i…
English 7.2 KB
2025-05-14 12:39
Declaration of Voting Results & Voting Rights Announcements
Minutes from the annual general meeting 2025
Norwegian 1.5 MB
2025-05-14 12:39
Declaration of Voting Results & Voting Rights Announcements
Minutes from the annual general meeting 2025
English 1.6 KB
2025-04-30 11:41
General Meeting Notice
Notice of Annual General Meeting
Norwegian 374.9 KB
2025-04-30 11:41
General Meeting Notice
Notice of Annual General Meeting
English 3.4 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo 1NKEMIA Spain IKM
2cureX AB Logo 2cureX AB Sweden 2CUREX
4SC AG Logo 4SC AG Germany VSC
Abera Bioscience AB Logo Abera Bioscience AB Sweden ABERA
ABIONYX Pharma Logo ABIONYX Pharma France ABNX
Abliva Logo Abliva Sweden ABLI
AB Science Logo AB Science France AB
Acticor Biotech Logo Acticor Biotech France ALACT
Active Biotech Logo Active Biotech Sweden ACTI
AcuCort AB Logo AcuCort AB Sweden ACUC